Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 39, Issue 10, Pages 1818-1836
Publisher
Wiley
Online
2019-08-22
DOI
10.1111/liv.14222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
- (2019) Alastair Heffernan et al. LANCET
- Countdown to 2030: eliminating hepatitis B disease, China
- (2019) Jue Liu et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia
- (2019) Joseph S. Doyle et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- On the way to Hepatitis C elimination in the Republic of Georgia—Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study
- (2019) Ivdity Chikovani et al. PLoS One
- Effects of Treatment of Chronic HBV Infection on Patient-reported Outcomes
- (2018) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
- (2018) Robert Hecht et al. HEALTH POLICY AND PLANNING
- Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis
- (2018) S. Hutchinson et al. JOURNAL OF HEPATOLOGY
- Hepatitis C elimination by 2030 is feasible in Brazil: a mathematical modelling approach
- (2018) A. Benzaken et al. JOURNAL OF HEPATOLOGY
- Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience
- (2018) Aisha Elsharkawy et al. JOURNAL OF HEPATOLOGY
- The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
- (2018) Kelly Safreed-Harmon et al. SEMINARS IN LIVER DISEASE
- How far are we from viral hepatitis elimination service coverage targets?
- (2018) Yvan J-F Hutin et al. Journal of the International AIDS Society
- Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour
- (2018) Nick Scott et al. Journal of the International AIDS Society
- Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study
- (2018) Nick Scott et al. Lancet Global Health
- Pathways to ensure universal and affordable access to hepatitis C treatment
- (2018) Caitlin H. Douglass et al. BMC Medicine
- Hepatitis C test uptake among historic blood transfusion recipients following media coverage of the Penrose Inquiry and an awareness-raising campaign
- (2018) Allan McLeod et al. JOURNAL OF VIRAL HEPATITIS
- Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030
- (2017) Gregory J. Dore et al. JOURNAL OF HEPATOLOGY
- Micro-elimination – A path to global elimination of hepatitis C
- (2017) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- Limited impact of awareness-raising campaigns on hepatitis C testing practices among general practitioners
- (2017) A. McLeod et al. JOURNAL OF VIRAL HEPATITIS
- Historical epidemiology of hepatitis C virus in select countries-volume 4
- (2017) A. Maaroufi et al. JOURNAL OF VIRAL HEPATITIS
- Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention
- (2017) H. H. Ayoub et al. JOURNAL OF VIRAL HEPATITIS
- National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
- (2017) W. El-Akel et al. JOURNAL OF VIRAL HEPATITIS
- Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
- (2017) Yibeltal Assefa et al. Globalization and Health
- Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
- (2017) Jason Grebely et al. Journal of the International AIDS Society
- Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
- (2017) Louisa Degenhardt et al. Lancet Global Health
- Hepatitis C Action Plan for Scotland: Phase II (May 2008-March 2011)
- (2017) D Goldberg et al. Eurosurveillance
- The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy
- (2016) Fabio Mesquita et al. BMC PUBLIC HEALTH
- Hepatitis C: global epidemiology and strategies for control
- (2016) S. Lanini et al. CLINICAL MICROBIOLOGY AND INFECTION
- The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs
- (2016) C. K. AITKEN et al. EPIDEMIOLOGY AND INFECTION
- Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model
- (2016) Nick Scott et al. GUT
- Investment Case for a Comprehensive Package of Interventions against Hepatitis B in China
- (2016) S. Nayagam et al. JOURNAL OF HEPATOLOGY
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Requirements for global elimination of hepatitis B: a modelling study
- (2016) Shevanthi Nayagam et al. LANCET INFECTIOUS DISEASES
- Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
- (2016) Louisa Degenhardt et al. LANCET INFECTIOUS DISEASES
- The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
- (2016) Amr Kandeel et al. LIVER INTERNATIONAL
- Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States
- (2016) Elana S. Rosenthal et al. Infectious Agents and Cancer
- National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016
- (2016) Lia Gvinjilia et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries
- (2015) Z. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2
- (2015) V. Saraswat et al. JOURNAL OF VIRAL HEPATITIS
- Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3
- (2015) V. Liakina et al. JOURNAL OF VIRAL HEPATITIS
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- A Public Health Approach to Hepatitis C Control in Low- and Middle-Income Countries
- (2015) Amitabh B. Suthar et al. PLOS MEDICINE
- Launch of a Nationwide Hepatitis C Elimination Program — Georgia, April 2015
- (2015) Kiren Mitruka et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The successful implementation of Scotland’s Hepatitis C Action Plan: what can other European stakeholders learn from the experience? A Scottish voluntary sector perspective
- (2014) Leon Wylie et al. BMC INFECTIOUS DISEASES
- Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?
- (2014) Hamish Innes et al. GUT
- Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing
- (2014) Allan McLeod et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Historical epidemiology of hepatitis C virus (HCV) in selected countries
- (2014) P. Bruggmann et al. JOURNAL OF VIRAL HEPATITIS
- Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions
- (2014) Norah E. Palmateer et al. PLoS One
- Use of laboratory-based surveillance data to estimate the number of people chronically infected with hepatitis B living in Scotland
- (2013) C. SCHNIER et al. EPIDEMIOLOGY AND INFECTION
- The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization
- (2013) M.A. Kane et al. VACCINE
- Origins, design and implementation of the China GAVI project
- (2013) Xiaofeng Liang et al. VACCINE
- Improving hepatitis B vaccine timely birth dose coverage: Lessons from five demonstration projects in China, 2005–2009
- (2013) Yvan Hutin et al. VACCINE
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
- (2012) J.J. Ott et al. VACCINE
- The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
- (2011) Katy M. E. Turner et al. ADDICTION
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
- (2011) Markus Cornberg et al. LIVER INTERNATIONAL
- The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities
- (2011) Marco daCosta DiBonaventura et al. JOURNAL OF MEDICAL ECONOMICS
- HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
- (2010) Bradley M Mathers et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation